MFE23-ZZ
(Plasmid
#223553)
-
PurposeMFE23-ZZ, a bispecific adaptor molecule, was created by fusing a scFv, termed MFE23, recognizing carcinoembryonic antigen to protein ZZ, which binds to the Fc fragment of IgG.
-
Depositing Lab
-
Sequence Information
-
Sequences (2) — Accept Affinity Reagent Sequence Policy
-
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 223553 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepET302NT-his
-
Backbone manufacturerThermofisher
- Backbone size w/o insert (bp) 5712
- Total vector size (bp) 6953
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)BL21 (DE3)
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert namepET302-MFE23-ZZ
-
SpeciesM. musculus (mouse); S. aureus
-
Insert Size (bp)1269
- Promoter T7
-
Tags
/ Fusion Proteins
- HA tag (N terminal on insert)
- HIS tag (N terminal on backbone)
Cloning Information
- Cloning method Unknown
- 5′ sequencing primer 5′-TAATACGACTCACTATAGGG-3′
- 3′ sequencing primer 5’-TAGTTATTGCTCAGCGGTGG-3’ (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byThermofisher Geneart Gene Synthesis
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Addgene comment: Note that there are some differences between the Addgene verified sequence and the depositor's reference sequence (see supplemental document). These differences do not affect the function of the plasmid.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
MFE23-ZZ was a gift from Jean Gariepy (Addgene plasmid # 223553 ; http://n2t.net/addgene:223553 ; RRID:Addgene_223553) -
For your References section:
Broadly Applicable Bispecific Linker Approach to Noncovalently Target Therapeutic Nanoparticles to Tumor Cells Expressing Carcinoembryonic Antigen. Fernando A, Sparkes A, Matus EI, Patel A, Foster FS, Goertz D, Lee P, Gariepy J. ACS Pharmacol Transl Sci. 2024 Jun 3;7(6):1864-1873. doi: 10.1021/acsptsci.4c00140. eCollection 2024 Jun 14. 10.1021/acsptsci.4c00140 PubMed 38898951